Mitigating risk in the development of clinical antibodies

The commercial development of therapeutic antibodies is not without its risks.

Bioinformatics, Biomedical Research, Business, Immunotherapy, Protein Engineering, Structural BiologyGordon WebsterJune 8, 2021antibodies, protein engineering, structural biology, bioinformatics, immunology, immunotherapy

Amber Biology to become an underwriter on NPR

Amber Biology will be helping NPR bring you the news and other current affairs programs on our local station WBUR which serves the Boston area.

Amber Biology, BusinessGordon WebsterApril 9, 2021#npr #wbur #radio #underwriting #currentaffairs #mediacoverage #media #press #bioinformatics #computationalbiology #biology #lifesciences, npr, wbur, radio, underwriting, current affairs, media coverage, media, press, bioinformatics, computational biology, biology, lifesciences

Intensive 3-day online Python course May 12-14, 2021

Are you a life science researcher who would love to use Python in your research, but have no prior coding experience? This intensive, live, 3-day online course was designed for you.

Algorithms, Bioinformatics, Biomedical Research, Computational Biology, Mathematical Biology, Modeling & Simulation, Python, Software Development, Training, Statistical AnalysisGordon WebsterApril 5, 2021#python #coding #bioinformatics #computationalbiology #genomics

Amber Biology rolls out its new antibody analysis service

A unique service that will be an invaluable resource to any team that is developing clinical antibodies

Gordon WebsterJanuary 27, 2021